These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16562975)

  • 21. Ligand prediction from protein sequence and small molecule information using support vector machines and fingerprint descriptors.
    Geppert H; Humrich J; Stumpfe D; Gärtner T; Bajorath J
    J Chem Inf Model; 2009 Apr; 49(4):767-79. PubMed ID: 19309114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of ranking methods for virtual screening in lead-discovery programs.
    Wilton D; Willett P; Lawson K; Mullier G
    J Chem Inf Comput Sci; 2003; 43(2):469-74. PubMed ID: 12653510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accurate prediction of enzyme mutant activity based on a multibody statistical potential.
    Masso M; Vaisman II
    Bioinformatics; 2007 Dec; 23(23):3155-61. PubMed ID: 17977887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of data fusion methods in virtual screening: theoretical model.
    Whittle M; Gillet VJ; Willett P; Loesel J
    J Chem Inf Model; 2006; 46(6):2193-205. PubMed ID: 17125164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of methods based on diversity and similarity for molecule selection and the analysis of drug discovery data.
    Lam RL; Welch WJ
    Methods Mol Biol; 2004; 275():301-16. PubMed ID: 15141118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
    Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
    Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Training similarity measures for specific activities: application to reduced graphs.
    Birchall K; Gillet VJ; Harper G; Pickett SD
    J Chem Inf Model; 2006; 46(2):577-86. PubMed ID: 16562986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.
    Oltulu O; Yaşar MM; Eroğlu E
    Eur J Med Chem; 2009 Sep; 44(9):3439-44. PubMed ID: 19303173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for new antidepressant leads of multiple activities by support vector machines.
    Lepp Z; Kinoshita T; Chuman H
    J Chem Inf Model; 2006; 46(1):158-67. PubMed ID: 16426052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melting point prediction employing k-nearest neighbor algorithms and genetic parameter optimization.
    Nigsch F; Bender A; van Buuren B; Tissen J; Nigsch E; Mitchell JB
    J Chem Inf Model; 2006; 46(6):2412-22. PubMed ID: 17125183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Representation of chemical information in OASIS centralized 3D database for existing chemicals.
    Nikolov N; Grancharov V; Stoyanova G; Pavlov T; Mekenyan O
    J Chem Inf Model; 2006; 46(6):2537-51. PubMed ID: 17125194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compounds.
    Ma XH; Wang R; Yang SY; Li ZR; Xue Y; Wei YC; Low BC; Chen YZ
    J Chem Inf Model; 2008 Jun; 48(6):1227-37. PubMed ID: 18533644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of 3D QSAR models for database screening: a feasibility study.
    Hillebrecht A; Klebe G
    J Chem Inf Model; 2008 Feb; 48(2):384-96. PubMed ID: 18211050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A knowledge-based weighting approach to ligand-based virtual screening.
    Stiefl N; Zaliani A
    J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioisosteric similarity of molecules based on structural alignment and observed chemical replacements in drugs.
    Krier M; Hutter MC
    J Chem Inf Model; 2009 May; 49(5):1280-97. PubMed ID: 19402687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FieldChopper, a new tool for automatic model generation and virtual screening based on molecular fields.
    Kalliokoski T; Ronkko T; Poso A
    J Chem Inf Model; 2008 Jun; 48(6):1131-7. PubMed ID: 18489083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIPALSTREE: a new hierarchical clustering approach for large compound libraries and its application to virtual screening.
    Böcker A; Schneider G; Teckentrup A
    J Chem Inf Model; 2006; 46(6):2220-9. PubMed ID: 17125166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
    J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.